Phaarmasia logo

Phaarmasia

PHAARMASIALTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹60.10 Cr
Volatility
Moderate
P/E Ratio
3.4
EBITDA
₹2.80 Cr
Return on Equity
79.53%
Debt to Equity
0.05
Book Value
₹32.36
EPS
₹0.03
52W High
₹131.75
52W Low
₹30.01

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 60.8 to 39.7 days.

Weaknesses

4
  • Stock is trading at 2.66 times its book value
  • Company has a low return on equity of -19.5% over last 3 years.
  • Earnings include an other income of Rs.19.9 Cr.
  • Working capital days have increased from -17.3 days to 62.1 days

Growth Rate

Revenue Growth
92.03% higher than 3Y
Net Income Growth
—
Cash Flow Change
945%
ROE
-537% lower than 3Y
ROCE
-646%
EBITDA Margin (Avg.)
-217%

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
6.88
8.64
5.08
9.99
8.29
5.93
4.72
5.43
6.87
16.55
16.05
7.73
8.28
Expenses
7.19
8.91
5.65
9.66
8.11
6.72
5.51
6.04
6.78
14.94
15.21
8.39
8.23
Operating Profit
-0.31
-0.27
-0.57
0.33
0.18
-0.79
-0.79
-0.61
0.09
1.61
0.84
-0.66
0.05
OPM %
-4.51%
-3.12%
-11.22%
3.3%
2.17%
-13.32%
-16.74%
-11.23%
1.31%
9.73%
5.23%
-8.54%
0.6%
Other Income
0.14
0.2
0.13
0.19
0.15
0.22
0.19
0.18
0.32
0.14
19.16
0.34
0.3
Interest
0.01
0.01
0.02
0
0
0
0.01
0
0.03
0
0.02
0.18
0.01
Depreciation
0.09
0.09
0.08
0.09
0.08
0.08
0.08
0.08
0.06
0.05
0.06
0.04
0.03
PBT
-0.27
-0.17
-0.54
0.43
0.25
-0.65
-0.69
-0.51
0.32
1.7
19.92
-0.54
0.31
Tax %
0%
-5.88%
3.7%
-9.3%
-12%
0%
1.45%
1.96%
12.5%
-2.35%
18.27%
31.48%
-9.68%
Net Profit
-0.27
-0.16
-0.56
0.47
0.28
-0.64
-0.7
-0.53
0.27
1.74
16.27
-0.7
0.34
EPS in Rs
-0.4
-0.23
-0.82
0.69
0.41
-0.94
-1.03
-0.78
0.4
2.55
23.83
-1.03
0.5
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
12
14
14
19
24
20
16
17
27
31
24
47
49
Expenses
11
13
14
18
23
19
16
19
29
31
26
45
47
Operating Profit
1
1
0
1
1
1
0
-2
-2
-1
-2
2
2
OPM %
8%
5%
1%
3.5%
3%
4.1%
-0.4%
-10%
-6%
-2.7%
-8%
4%
3.8%
Other Income
0
0
1
1
1
1
1
0
1
1
1
20
20
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
1
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
1
1
1
0
-2
-1
-1
-2
21
21
Tax %
39%
83%
37%
16%
6%
45%
33%
-1%
-12%
-6%
-1%
18%
—
Net Profit
0
0
0
1
1
1
0
-2
-1
-1
-2
18
18
EPS in Rs
0.21
0.06
0.23
0.83
1.14
0.79
0.45
-2.27
-1.85
-0.76
-2.33
25.74
25.85
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
7
7
7
7
7
7
7
7
7
Reserves
6
5
5
5
6
7
7
5
4
3
2
15
Borrowings
0
0
0
0
0
0
0
0
0
0
0
1
Other Liabilities
6
7
8
10
20
20
8
9
17
21
13
7
Total Liabilities
19
19
20
22
33
34
22
21
28
31
22
30
Fixed Assets
16
14
14
14
14
13
13
13
13
12
12
1
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
4
5
6
8
19
20
9
8
16
19
9
29
Total Assets
19
19
20
22
33
34
22
21
28
31
22
30
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
0
0
1
0
0
0
0
1
0
-3
22
Investing
0
0
0
-1
0
0
0
0
0
0
0
-12
Financing
0
0
0
0
0
0
0
0
0
0
0
1
Net Cash Flow
0
0
0
0
0
0
0
0
0
0
-3
11
Free Cash Flow
0
0
0
0
0
0
0
0
1
0
-3
9
CFO/OP
59
68
21
153
32
41
-817
1
-42
-13
127
1,153
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
48
78
91
73
179
226
96
69
100
96
47
40
Inventory Days
80
12
56
43
135
125
66
112
103
126
57
48
Days Payable
185
216
293
249
403
374
166
214
269
298
224
23
Cash Conversion Cycle
-56
-127
-146
-133
-89
-24
-4
-33
-65
-76
-120
64
Working Capital Days
-79
-64
-43
-34
-13
7
8
-17
-39
-43
-71
62
ROCE %
3%
2%
2%
6%
7%
8%
4%
-12%
-12%
-5%
-16%
16%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Phaarmasia insights

59 extracted metrics + investor summaries across FY09–FY26.

Log in — free

Shareholding Pattern

DIIs0.06%Promot.73.51%Others0.76%Public25.67%As ofJun 2026

Documents

Frequently Asked Questions about Phaarmasia

What does Phaarmasia Ltd do?
Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets
Where is Phaarmasia Ltd (523620) listed?
Phaarmasia Ltd trades as PHAARMASIALTD on the NSE and under code 523620 on the BSE.
Which sector does Phaarmasia Ltd belong to?
Phaarmasia Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the market capitalisation of Phaarmasia Ltd?
Phaarmasia Ltd has a market capitalisation of ₹60.1 Cr, which places it in the Small Cap band.
What is the PE ratio of Phaarmasia Ltd?
Phaarmasia Ltd trades at a PE ratio of 3.40, on earnings per share of ₹0.03, against a book value of ₹32.36 per share.
What is the 52-week high and low of Phaarmasia Ltd?
Over the last 52 weeks Phaarmasia Ltd has traded between ₹30.01 and ₹131.75.
What is the Return on Equity (ROE) of Phaarmasia Ltd?
Phaarmasia Ltd reported a return on equity of 79.53%. Its debt-to-equity ratio is 0.05.

Company Information

Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets

Website phaarmasia.in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/523620.md for Phaarmasia Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List